Quick Answer
REGENXBIO Inc. reported Common Stock Shares Outstanding of 50.89 million shares for the year ending 2025.
- REGENXBIO Inc. showed an increase of +2.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from REGENXBIO Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), REGENXBIO Inc.'s Common Stock Shares Outstanding has grown by 1,824.1%.
- Historical annual values: Fiscal year 2025: 50.89 million shares | Fiscal year 2024: 49.55 million shares | Fiscal year 2023: 44.05 million shares | Fiscal year 2022: 43.30 million shares | Fiscal year 2021: 42.83 million shares | Fiscal year 2020: 37.48 million shares | Fiscal year 2019: 36.99 million shares | Fiscal year 2018: 36.12 million shares | Fiscal year 2017: 31.30 million shares | Fiscal year 2016: 26.48 million shares | Fiscal year 2015: 26.31 million shares | Fiscal year 2014: 2.65 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: